Modified arginine deiminase
US6183738A · kind A · utility
102Cited by
7References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 13, 1998 |
| Grant date | Feb 6, 2001 |
| Priority date | — |
| Expiry date | Feb 13, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to arginine deiminase modified with polyethylene glycol, to methods of treating cancer, and to methods of treating and/or inhibiting metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.